XOMA is a leading biopharmaceutical company in the field of therapeutic antibody discovery and development. We have a royalty interest in one approved therapeutic antibody, RAPTIVAŽ (efalizumab),... www.xoma.com/View full profile
TL Biopharmaceuticals Ltd. ("XTL") is engaged in the acquisition, development and commercialization of therapeutics for the treatment of neuropathic pain and hepatitis C. XTL is developing Bicifadine,... www.xtlbio.comView full profile
Xtrana's mission is to simplify the analysis of DNA/RNA, so that nucleic acid based detection systems can be utilized not only in traditional laboratory settings, but also in point-of-care, point-of... www.xtrana.com/View full profile
Xceleron Ltd is the new name for 'The Centre for Biomedical Accelerator Mass Spectrometry' (CBAMS Ltd). Reflecting our aim of accelerating drug development, Xceleron is the world's foremost company... www.cbams.co.uk/View full profile
Xenobiotic Detection Systems (XDS) was started in 1995 by Drs. George C. Clark and Michael S. Denison. In 1997 XDS received major Research and Development funding from the National Institutes of... www.dioxins.com/View full profile